The Memorial Sloan Kettering Prognostic Score: Correlation with survival in patients with advanced gastric cancer.

ABSTRACT:

Background

Notwithstanding that the past decade has witnessed unprecedented medical progress, gastric cancer (GC) remains a leading cause of cancer death, highlighting the need for effective prognostic markers. The Memorial Sloan Kettering Prognostic Score (MPS) has been validated as a valuable prognostic tool for patients with metastatic pancreatic adenocarcinoma (mPDAC). This study aimed to assess the prognostic value of the MPS in advanced GC.

Methods

Data from 367 patients were analyzed in the present study. The MPS for each patient was calculated based on the sum of scores based on the neutrophil-to-lymphocyte ratio and serum albumin levels. Multivariate analyses were performed to identify the independent clinicopathological parameters associated with overall survival (

SUBMITTER: Wan M 

PROVIDER: S-EPMC10587931 | biostudies-literature | 2023 Oct

REPOSITORIES: biostudies-literature